Advertisement
Screener

BONE BIOLOGICS CORPORATION (BBLG) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

2.8 / 5 stars · 68/120 Roast Me

BONE BIOLOGICS CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)

BONE BIOLOGICS CORPORATION (BBLG) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of $157 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2026-08-14

  • BONE BIOLOGICS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-06-30 was -$108.00, a 111.97% decline year-over-year.
  • BONE BIOLOGICS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2026-03-31 was $265.00, a 80.44% decline year-over-year.
  • BONE BIOLOGICS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-12-31 was $498.00, a 96.16% decline year-over-year.
  • BONE BIOLOGICS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2025-09-30 was $1.21K.
  • BONE BIOLOGICS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2025 was $3.97K, a 92.23% decline from fiscal 2024.
  • BONE BIOLOGICS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2024 was $51.08K.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month
2026-06-30-$108.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$157.00
10-Q · filed 2026-08-14
$655.00
derived: sum of 3 quarters · filed 2026-08-14
$1.87K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$265.00
10-Q · filed 2026-05-14
$763.00
derived: sum of 2 quarters · filed 2026-05-14
$1.98K
derived: sum of 3 quarters · filed 2026-05-14
$2.88K
derived: sum of 4 quarters · filed 2026-05-14
2025-12-31$498.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$1.71K
derived: sum of 2 quarters · filed 2026-03-02
$2.61K
derived: sum of 3 quarters · filed 2026-03-02
$3.97K
10-K · filed 2026-03-02
2025-09-30$1.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$2.11K
derived: sum of 2 quarters · filed 2025-11-14
$3.47K
10-Q · filed 2025-11-14
$16.43K
derived: sum of 4 quarters · filed 2025-11-14
2025-06-30$902.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$2.26K
10-Q · filed 2025-08-14
$15.22K
derived: sum of 3 quarters · filed 2025-08-14
$5.24K
derived: sum of 4 quarters · filed 2025-08-14
2025-03-31$1.35K
10-Q · filed 2025-05-12
$14.31K
derived: sum of 2 quarters · filed 2025-05-12
$4.34K
derived: sum of 3 quarters · filed 2025-05-12
2024-12-31$12.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$2.98K
derived: sum of 2 quarters · filed 2025-02-26
$51.08K
10-K · filed 2025-02-26
2024-09-30-$9.97K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$38.12K
10-Q · filed 2024-11-14
2024-06-30$48.10K
10-Q · filed 2024-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
LogicMark, Inc. (LGMK)United States$0.000B
ENvue Medical, Inc. (FEED)United States$0.011B
Lifeward Ltd. (LFWD)$0.021B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B